Cationic gelatin nanoparticles for drug delivery to the ocular surface: In vitro and in vivo evaluation

Ching Li Tseng, Ko Hua Chen, Wen Yu Su, Yen Hsien Lee, Chi Chang Wu, Fen Huei Lin

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

To develop an effective ocular drug delivery carrier, we prepared two different charged gelatin nanoparticles (GPs) and evaluated particle size, surface charge, and morphology. The in vitro biocompatibility of GPs was assessed using human corneal epithelium (HCE) cells and in vivo safety by administering them as eye drops to New Zealand rabbits. The GPs prepared using type A gelatin were positively charged (GP(+), +33 mV; size, 180.6 ± 45.7 nm). Water-soluble tetrazolium salt (WST)-1 assay showed that both GPs were nontoxic to HCE cells. The fluorescence intensity of HCE cells cultured with cationic GPs conjugated with a fluorescent dye was higher than that of the anionic GP-treated HCE cells. In vivo examination showed no serious irritation to the rabbit eyes. Furthermore, corneal thickness and ocular pressure in the eyes of the treated rabbits were similar to those in the eyes of normal rabbits. Microscopic examination of corneal cryosections showed widely distributed fluorescent nanocarriers, from the anterior to the posterior part of the cornea of the GP(+) group, and higher fluorescence intensity in the GP(+) group was also observed. In conclusion, GPs as cationic colloidal carriers were efficiently adsorbed on the negatively charged cornea without irritating the eyes of the rabbits and can be retained in the cornea for a longer time. Thus, GPs(+) have a great potential as vehicles for ocular drug delivery.

Original languageEnglish
Article number238351
JournalJournal of Nanomaterials
Volume2013
DOIs
Publication statusPublished - 2013

Fingerprint

Gelatin
Drug delivery
Nanoparticles
Fluorescence
Tetrazolium Salts
Ophthalmic Solutions
Surface charge
Biocompatibility
Fluorescent Dyes
Surface morphology
Assays
Microscopic examination
Dyes
Particle size
Salts

ASJC Scopus subject areas

  • Materials Science(all)

Cite this

Cationic gelatin nanoparticles for drug delivery to the ocular surface : In vitro and in vivo evaluation. / Tseng, Ching Li; Chen, Ko Hua; Su, Wen Yu; Lee, Yen Hsien; Wu, Chi Chang; Lin, Fen Huei.

In: Journal of Nanomaterials, Vol. 2013, 238351, 2013.

Research output: Contribution to journalArticle

Tseng, Ching Li ; Chen, Ko Hua ; Su, Wen Yu ; Lee, Yen Hsien ; Wu, Chi Chang ; Lin, Fen Huei. / Cationic gelatin nanoparticles for drug delivery to the ocular surface : In vitro and in vivo evaluation. In: Journal of Nanomaterials. 2013 ; Vol. 2013.
@article{e35517f01d9a4ab587eed87e2c3870a1,
title = "Cationic gelatin nanoparticles for drug delivery to the ocular surface: In vitro and in vivo evaluation",
abstract = "To develop an effective ocular drug delivery carrier, we prepared two different charged gelatin nanoparticles (GPs) and evaluated particle size, surface charge, and morphology. The in vitro biocompatibility of GPs was assessed using human corneal epithelium (HCE) cells and in vivo safety by administering them as eye drops to New Zealand rabbits. The GPs prepared using type A gelatin were positively charged (GP(+), +33 mV; size, 180.6 ± 45.7 nm). Water-soluble tetrazolium salt (WST)-1 assay showed that both GPs were nontoxic to HCE cells. The fluorescence intensity of HCE cells cultured with cationic GPs conjugated with a fluorescent dye was higher than that of the anionic GP-treated HCE cells. In vivo examination showed no serious irritation to the rabbit eyes. Furthermore, corneal thickness and ocular pressure in the eyes of the treated rabbits were similar to those in the eyes of normal rabbits. Microscopic examination of corneal cryosections showed widely distributed fluorescent nanocarriers, from the anterior to the posterior part of the cornea of the GP(+) group, and higher fluorescence intensity in the GP(+) group was also observed. In conclusion, GPs as cationic colloidal carriers were efficiently adsorbed on the negatively charged cornea without irritating the eyes of the rabbits and can be retained in the cornea for a longer time. Thus, GPs(+) have a great potential as vehicles for ocular drug delivery.",
author = "Tseng, {Ching Li} and Chen, {Ko Hua} and Su, {Wen Yu} and Lee, {Yen Hsien} and Wu, {Chi Chang} and Lin, {Fen Huei}",
year = "2013",
doi = "10.1155/2013/238351",
language = "English",
volume = "2013",
journal = "Journal of Nanomaterials",
issn = "1687-4110",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Cationic gelatin nanoparticles for drug delivery to the ocular surface

T2 - In vitro and in vivo evaluation

AU - Tseng, Ching Li

AU - Chen, Ko Hua

AU - Su, Wen Yu

AU - Lee, Yen Hsien

AU - Wu, Chi Chang

AU - Lin, Fen Huei

PY - 2013

Y1 - 2013

N2 - To develop an effective ocular drug delivery carrier, we prepared two different charged gelatin nanoparticles (GPs) and evaluated particle size, surface charge, and morphology. The in vitro biocompatibility of GPs was assessed using human corneal epithelium (HCE) cells and in vivo safety by administering them as eye drops to New Zealand rabbits. The GPs prepared using type A gelatin were positively charged (GP(+), +33 mV; size, 180.6 ± 45.7 nm). Water-soluble tetrazolium salt (WST)-1 assay showed that both GPs were nontoxic to HCE cells. The fluorescence intensity of HCE cells cultured with cationic GPs conjugated with a fluorescent dye was higher than that of the anionic GP-treated HCE cells. In vivo examination showed no serious irritation to the rabbit eyes. Furthermore, corneal thickness and ocular pressure in the eyes of the treated rabbits were similar to those in the eyes of normal rabbits. Microscopic examination of corneal cryosections showed widely distributed fluorescent nanocarriers, from the anterior to the posterior part of the cornea of the GP(+) group, and higher fluorescence intensity in the GP(+) group was also observed. In conclusion, GPs as cationic colloidal carriers were efficiently adsorbed on the negatively charged cornea without irritating the eyes of the rabbits and can be retained in the cornea for a longer time. Thus, GPs(+) have a great potential as vehicles for ocular drug delivery.

AB - To develop an effective ocular drug delivery carrier, we prepared two different charged gelatin nanoparticles (GPs) and evaluated particle size, surface charge, and morphology. The in vitro biocompatibility of GPs was assessed using human corneal epithelium (HCE) cells and in vivo safety by administering them as eye drops to New Zealand rabbits. The GPs prepared using type A gelatin were positively charged (GP(+), +33 mV; size, 180.6 ± 45.7 nm). Water-soluble tetrazolium salt (WST)-1 assay showed that both GPs were nontoxic to HCE cells. The fluorescence intensity of HCE cells cultured with cationic GPs conjugated with a fluorescent dye was higher than that of the anionic GP-treated HCE cells. In vivo examination showed no serious irritation to the rabbit eyes. Furthermore, corneal thickness and ocular pressure in the eyes of the treated rabbits were similar to those in the eyes of normal rabbits. Microscopic examination of corneal cryosections showed widely distributed fluorescent nanocarriers, from the anterior to the posterior part of the cornea of the GP(+) group, and higher fluorescence intensity in the GP(+) group was also observed. In conclusion, GPs as cationic colloidal carriers were efficiently adsorbed on the negatively charged cornea without irritating the eyes of the rabbits and can be retained in the cornea for a longer time. Thus, GPs(+) have a great potential as vehicles for ocular drug delivery.

UR - http://www.scopus.com/inward/record.url?scp=84896139265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896139265&partnerID=8YFLogxK

U2 - 10.1155/2013/238351

DO - 10.1155/2013/238351

M3 - Article

AN - SCOPUS:84896139265

VL - 2013

JO - Journal of Nanomaterials

JF - Journal of Nanomaterials

SN - 1687-4110

M1 - 238351

ER -